腹腔镜联合生物蛋白胶用于卵巢囊肿剥除及卵巢成形术的临床研究  

A Comparison of Laparotomy and Laparoscopy in the Treatment of Ovarian Cysts

作　　者：周友珍[1] 范艳玲 林凤[1] 

机构地区：[1]首都医科大学附属北京世纪坛医院妇产科,北京100038 [2]北京市海淀区北蜂窝医院,北京100038

出　　处：《中国医药指南》2012年第6期14-16,共3页Guide of China Medicine

摘　　要：目的通过对开腹和腹腔镜下良性卵巢囊肿剥除及卵巢成形术的比较,探讨腹腔镜联合生物蛋白胶的临床应用价值。方法分析了2003年1月至2010年3月间在腹腔镜下行卵巢囊肿剥除、生物蛋白胶行卵巢成形术的患者130例,与同期83例按常规开腹手术治疗的良性卵巢囊肿病例作为对照。结果两组患者在年龄、体质量、囊肿性质及大小、剖腹术史、手术时间及住院费用等差异无显著性(P>0.05)。但腹腔镜组术中出血量、术后病率及镇痛情况、术后排气时间、术后自主活动的时间和住院天数均明显低于开腹组(P<0.05)。结论腹腔镜配合生物蛋白胶治疗良性卵巢囊肿具有安全、有效、微创、简单的特点,适合于广泛开展。Objective To compare the results of cystectomy laparoseopicly and laparotomiely in the management of benign ovarian cysts, and to evaluate the value of combined laparoscopic operation with fibrin sealant. Methods 213 patients with benign ovarian cysts requiring operation from January, 2003 to March, 2010 were randomly divided into laparoscopy group（130 cases） and laparotomy group （83 cases）. The characteristics of patients and results of laparoscopy and laparotomy in the cystectomyof ovarian cysts were compared. Results There were no differences in age, body weight, the size of cysts, previous laparotomy, the operation time and the hospitalization fee between two groups（P〉0.05）. The amount of blood lost during the operation, postoperative morbidity, analgestic requirement, hospital stay and recovery period in laparoscopic group were significantly less than those in laparotomy（P 〈 0.05）. Conclusion The combined laparoscopic surgery with fibrin sealant is safe and effective and feasible in the cystectomy of benign ovarian cysts.

关 键 词：卵巢囊肿 腹腔镜 生物蛋白胶 开腹手术 

分 类 号：R737.31[医药卫生—肿瘤]